VTE (VENOUS THROMBOEMBOLISM)
Clinical trials for VTE (VENOUS THROMBOEMBOLISM) explained in plain language.
Never miss a new study
Get alerted when new VTE (VENOUS THROMBOEMBOLISM) trials appear
Sign up with your email to follow new studies for VTE (VENOUS THROMBOEMBOLISM), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Could a once-daily pill cut deadly clots in cancer patients?
Disease control Recruiting nowThis study tests whether a blood thinner called apixaban can safely prevent dangerous blood clots in cancer patients at moderate risk. About 996 adults with solid tumors or lymphoma will be randomly assigned to take a standard twice-daily dose, a simpler once-daily dose, or no bl…
Matched conditions: VTE (VENOUS THROMBOEMBOLISM)
Phase: PHASE3 • Sponsor: University of Vermont • Aim: Disease control
Last updated May 22, 2026 14:04 UTC
-
Pill vs. needle: can Lower-Dose blood thinners protect cancer patients from deadly clots?
Disease control Recruiting nowThis study looks at whether lower doses of two blood-thinning pills (apixaban and rivaroxaban) work as well as standard injections to prevent dangerous blood clots in people with blood cancers like lymphoma, leukemia, and multiple myeloma. About 100 participants will be randomly …
Matched conditions: VTE (VENOUS THROMBOEMBOLISM)
Phase: NA • Sponsor: Medical University of Gdansk • Aim: Disease control
Last updated May 22, 2026 13:55 UTC